ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 162 filers reported holding ACHILLION PHARMACEUTICALS IN in Q3 2014. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2016 | $79,000 | -70.8% | 10,292 | -59.0% | 0.00% | -72.7% |
Q4 2015 | $271,000 | +23.2% | 25,080 | +0.8% | 0.01% | +37.5% |
Q2 2015 | $220,000 | +8.4% | 24,873 | +22.5% | 0.01% | +33.3% |
Q3 2014 | $203,000 | +28.5% | 20,308 | -2.6% | 0.01% | +50.0% |
Q2 2014 | $158,000 | – | 20,856 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MAK CAPITAL ONE LLC | 5,191,600 | $8,255,000 | 4.47% |
RTW INVESTMENTS, LP | 13,749,383 | $21,862,000 | 2.04% |
ARMISTICE CAPITAL, LLC | 4,300,000 | $6,837,000 | 0.52% |
DAFNA Capital Management LLC | 630,182 | $1,002,000 | 0.50% |
Rock Springs Capital Management LP | 2,325,000 | $3,697,000 | 0.18% |
683 Capital Management, LLC | 1,000,000 | $1,590,000 | 0.10% |
Alambic Investment Management, L.P. | 133,698 | $213,000 | 0.09% |
South Dakota Investment Council | 3,037,004 | $7,310,000 | 0.08% |
Alpine Global Management, LLC | 205,172 | $326,000 | 0.08% |
Rhenman & Partners Asset Management AB | 402,800 | $640,000 | 0.07% |